BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9187397)

  • 1. Reversed-phase high-performance liquid chromatographic determination of the new antitumor agent cyclopentenyl cytosine in biological fluids.
    Hegedus L; Ford H; Hartman NR; Kelley JA
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):169-79. PubMed ID: 9187397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopentenyl cytosine: interspecies predictions based on rodent plasma and urine kinetics.
    Zaharko DS; Kelley JA; Tomaszewski JE; Hegedus L; Hartman NR
    Invest New Drugs; 1991 Feb; 9(1):9-17. PubMed ID: 2026489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I clinical trial of continuous infusion cyclopentenyl cytosine.
    Politi PM; Xie F; Dahut W; Ford H; Kelley JA; Bastian A; Setser A; Allegra CJ; Chen AP; Hamilton JM
    Cancer Chemother Pharmacol; 1995; 36(6):513-23. PubMed ID: 7554044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates.
    Blaney SM; Balis FM; Hegedus L; Heideman RL; McCully C; Murphy RF; Kelley JA; Poplack DG
    Cancer Res; 1990 Dec; 50(24):7915-9. PubMed ID: 2253232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of cyclopentenyl cytosine 5'-triphosphate in vitro and in vivo by multidimensional high-performance liquid chromatography.
    Agbaria R; Ford H; Kelley JA; Xie F; Politi P; Grem JL; Cooney DA; Marquez VE; Allegra CJ; Johns DG
    Anal Biochem; 1993 Aug; 213(1):90-6. PubMed ID: 8238887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification method.
    Liu Z; Marcucci G; Byrd JC; Grever M; Xiao J; Chan KK
    Rapid Commun Mass Spectrom; 2006; 20(7):1117-26. PubMed ID: 16523529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
    Blaney SM; Grem JL; Balis FM; Cole DE; Adamson PC; Poplack DG
    Biochem Pharmacol; 1993 Apr; 45(7):1493-501. PubMed ID: 8471071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of 2'-deoxy-2'-β-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies.
    Peng Y; Cheng T; Dong L; Zhang Y; Chen X; Jiang J; Zhang J; Guo X; Guo M; Chang J; Wang Q
    J Pharm Biomed Anal; 2014 Sep; 98():379-86. PubMed ID: 24999865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the arotinoid mofarotene in human, rat and dog plasma by high-performance liquid chromatography with automated column switching and ultraviolet detection.
    Wyss R; Bucheli F; Hess B
    J Chromatogr A; 1996 Apr; 729(1-2):315-22. PubMed ID: 9004956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis of felotaxel, a novel anti-cancer drug, in rat plasma and in human plasma and urine.
    Yan L; YanYan J; MinChun C; Jing Y; Ying S; ChengTao L; Jie G; CaiYang L; ZhenXing Z; AiDong W; Yi D
    J Chromatogr Sci; 2013 Mar; 51(3):292-6. PubMed ID: 22933511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
    Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of perillic acid in plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Ikechukwu Ezennia E; Phillips LR; Wolfe TL; Esmail Tabibi S
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):354-8. PubMed ID: 9061476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a new polymer-bound paclitaxel derivative (PNU 166945), free paclitaxel and 7-epipaclitaxel in dog plasma and urine by reversed-phase high-performance liquid chromatography with UV detection.
    Fraier D; Cenacchi V; Frigerio E
    J Chromatogr A; 1998 Feb; 797(1-2):295-303. PubMed ID: 9542121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of FCE 26644, a new polysulphonated derivative of distamycin A, in monkey plasma by reversed-phase ion-pair high-performance liquid chromatography with ultraviolet detection.
    Frigerio E; Magi N; Benecchi A; Pianezzola E; Strolin Benedetti M
    J Chromatogr A; 1996 Apr; 729(1-2):237-42. PubMed ID: 9004945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detection.
    Hüttmann A; Mross K; Hossfeld DK
    J Chromatogr; 1993 Oct; 620(2):233-8. PubMed ID: 8300791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive high-performance liquid chromatographic assay for 1-beta-D-arabinofuranosylcytosine-5'-stearyl phosphate (cytarabine-ocfosfate).
    Ramsauer B; Braess J; Unterhalt M; Kaufmann CC; Hiddemann W; Schleyer E
    J Chromatogr B Biomed Appl; 1995 Mar; 665(1):183-92. PubMed ID: 7795790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic-ultraviolet assay for the simultaneous quantitation of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma.
    Shah VR; Srinivas NR; Campbell DA; Mantha S; Duncan G; Schuster A; Whigan DW; Shyu WC
    Biomed Chromatogr; 1996; 10(3):135-8. PubMed ID: 8792865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a rapid LC-MS/MS method for the determination of JCC76, a novel antitumor agent for breast cancer, in rat plasma and its application to a pharmacokinetics study.
    Cai X; Zhong B; Su B; Xu S; Guo B
    Biomed Chromatogr; 2012 Sep; 26(9):1118-24. PubMed ID: 22213194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a gradient elution high-performance liquid chromatography assay with ultraviolet detection for the determination in plasma of the anticancer peptide [Arg6, D-Trp7,9, mePhe8]-substance P (6-11) (antagonist G), its major metabolites and a C-terminal pyrene-labelled conjugate.
    Cummings J; MacLellan AJ; Mark M; Jodrell DI
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):277-85. PubMed ID: 10517349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.